Targeting Neutrophil Extracellular Traps in Gouty Arthritis: Insights into Pathogenesis and Therapeutic Potential
C Li, C Wu, F Li, W Xu, X Zhang… - Journal of Inflammation …, 2024 - Taylor & Francis
Gouty arthritis (GA) is an immune-mediated disorder characterized by severe inflammation
due to the deposition of monosodium urate (MSU) crystals in the joints. The …
due to the deposition of monosodium urate (MSU) crystals in the joints. The …
Nets in fibrosis: Bridging innate immunity and tissue remodeling
X Ma, J Li, M Li, G Qi, L Wei, D Zhang - International Immunopharmacology, 2024 - Elsevier
Fibrosis, a complex pathological process characterized by excessive deposition of
extracellular matrix components, leads to tissue scarring and dysfunction. Emerging …
extracellular matrix components, leads to tissue scarring and dysfunction. Emerging …
[HTML][HTML] Insight into antiphospholipid syndrome: the role and clinical utility of neutrophils extracellular traps formation
SEDGED Zaiema, MAZMAA Elwafa, SGA Hassan… - Thrombosis …, 2024 - Springer
Antiphospholipid syndrome (APLS) is a systemic immune dysregulation distinguished by
repetitive complications and pregnancy loss in the absence of definite etiology. Most …
repetitive complications and pregnancy loss in the absence of definite etiology. Most …
[PDF][PDF] Нетоз при волчаночном нефрите
ТМ Решетняк, КС Нурбаева, ИВ Пташник… - Терапевтический …, 2024 - omnidoctor.ru
Нетоз при волчаночном нефрите Page 1 https://doi.org/10.26442/00403660.2024.05.202699
ТЕРАПЕВТИЧЕСКИЙ АРХИВ. 2024; 96 (5): 453–458. TERAPEVTICHESKII ARKHIV. 2024; …
ТЕРАПЕВТИЧЕСКИЙ АРХИВ. 2024; 96 (5): 453–458. TERAPEVTICHESKII ARKHIV. 2024; …
NETosis in lupus nephritis
TM Reshetnyak, KS Nurbaeva, IV Ptashnik… - Terapevticheskii …, 2024 - ter-arkhiv.ru
Aim. To evaluate the levels of MPO-DNA complex in patients with systemic lupus
erythematosus (SLE) and its association with the presence of lupus nephritis (LN). Materials …
erythematosus (SLE) and its association with the presence of lupus nephritis (LN). Materials …
Эффективность и безопасность применения ингибитора рецепторов интерферона типа I анифролумаба у пациентов с системной красной волчанкой …
ТМ Решетняк, ЕА Асеева, АА Шумилова… - Современная …, 2024 - mrj.ima-press.net
Аннотация Цель исследования–оценить эффективность и безопасность ингибитора
рецепторов интерферона типа I анифролумаба (АФМ, Сафнело®) у пациентов с …
рецепторов интерферона типа I анифролумаба (АФМ, Сафнело®) у пациентов с …